ATC | Medicines | Adverse drug reaction | No | Indication of use | Age ofchild |
---|---|---|---|---|---|
N05A | Levopromazine | Priapism | 1 | Headache | 0 |
 | Olanzapine | Atrial septal defects | 1 | NA | 1 |
 |  | Blood glucose decreased | 1 | Schizophrenia | 0 |
 |  | Convulsion | 1 | NA | 0 |
 |  | Decreased appetite | 1 | Schizophrenia | 0 |
 |  | Drug exposure during pregnancy | 1 | NA* | 0 |
 |  | Failure to thrive | 1 | Schizophrenia | 0 |
 |  | Feeding disorder, neonatal | 1 | Schizophrenia | 0 |
 |  | Haemoglobin increased | 1 | NA | 1 |
 |  | Hypoxia | 1 | NA | 0 |
 |  | Pneumonia | 1 | NA | 1 |
 |  | Polycythaemia | 1 | NA | 1 |
 |  | Somnolence | 1 | Schizophrenia | 0 |
 |  | Tension | 1 | NA | 1 |
 | Risperidon | Drug withdrawal syndrome, neonatal | 1 | Depression | 0 |
 | Sulpirid | Agitation, neonatal | 1 | Depression | 0 |
 | Zuclopemthixol | Supraventricular tachycardia | 1 | Schizophrenia | 0 |
N05B | Buspirone | Ventricular septal defect | 1 | Depression | 0 |
 | Diazepam | Apnoea | 1 | Convulsions | 0 |
 | Oxazepam | Congenital acrochordon | 1 | Anxiety depression | 0 |
 |  | Chondropathy | 1 | Anxiety depression | 0 |
 |  | Drug exposure during pregnancy | 1 | Anxiety depression | 0 |
N06A | Amitriptyline | Epilepsy | 1 | Depression | 0 |
 |  | Febrile convulsion | 1 | Depression | 0 |
 | Clompipramine | Psychomotor retardation | 1 | NA | 0 |
 | Citalopram | Tremor, neonatal | 3 | Panic disorder | 1 |
 |  | Drug withdrawal syndrome, neonatal | 2 | Depression/Panic disorder | 0/1 |
 |  | Hypotonia, neonatal | 2 | Depression | 0 |
 |  | Irritability | 2 | Panic disorder | 0/1 |
 |  | Apnoea | 1 | NA* | 0 |
 |  | Asthenia | 1 | NA | 0 |
 |  | Chorioamnionitis | 1 | Depression | 0 |
 |  | Convulsion, neonatal | 1 | Depression | 0 |
 |  | Hypertonia | 1 | Panic disorder | 1 |
 |  | Hypocalcaemia | 1 | Depression | 0 |
 |  | Neonatal asphyxia | 1 | Depression | 0 |
 |  | Neonatal respiratory depression | 1 | NA* | 0 |
 |  | Oral candidiasis | 1 | Depression | 0 |
 |  | Pallor | 1 | NA* | 0 |
 |  | Premature labour | 1 | Depression | 0 |
 |  | Ventricular septal defect | 1 | Depression | 0 |
 | Escitalopram | Atrial septal defect | 1 | NA | 1 |
 |  | Drug exposure during pregnancy | 1 | NA* | 0 |
 | Fluoxetine | Drug withdrawal syndrome, neonatal | 3 | Depression | 0 |
 |  | Tremor | 2 | Depression | 0 |
 |  | Agitation, neonatal | 1 | Depression | 0 |
 |  | Bradycardia, neonatal | 1 | Depression | 0 |
 |  | Deafness neurosensory | 1 | NA | 0 |
 |  | Drug exposure during pregnancy | 1 | NA* | 0 |
 |  | Dyskinesia, neonatal | 1 | Depression | 0 |
 |  | Feeding disorder, neonatal | 1 | Depression | 0 |
 |  | Hypertonia, neonatal | 1 | Depression | 0 |
 |  | Neonatal disorder | 1 | Depression | 0 |
 |  | Persistent foetal circulation | 1 | Depression | 0 |
 |  | Upper limb deformity | 1 | Depression | 0 |
 | Paroxetine | Klinefelter's syndrome | 1 | NA | 0 |
 |  | Neonatal respiratory failure | 1 | NA* | 0 |
 |  | Psychomotor retardation | 1 | NA | 0 |
 | Sertraline | Respiration abnormal | 2 | Depression | 0 |
 |  | Cerebral palsy | 1 | Depression | 0 |
 |  | Circulatory collapse | 1 | Depression | 0 |
 |  | Cyanosis | 1 | Depression | 0 |
 |  | Drug withdrawal syndrome, neonatal | 1 | Depression | 0 |
 |  | Drug exposure during pregnancy | 1 | Depression | 0 |
 |  | Muscle spasms | 1 | Anxiety | 0 |
 |  | Myoclonus | 1 | Anxiety | 0 |
 |  | Persistent foetal circulation | 1 | Depression | 0 |
 |  | Pulmonary hypertension | 1 | Depression | 0 |
 | Mirtazapine | Cerebral palsy | 1 | Depression | 0 |
 | Venlafaxine | Agitation, neonatal | 1 | Depression | 0 |